drugset
drugset / Trial / NCT00545064

Dry Eye Study With Cosopt® Over 8 Weeks in Patients With Open-Angle Glaucoma or Ocular Hypertension (0507A-152)(COMPLETED)

NCT00545064 ↗

Phase 4 Completed 176 enrolled Merck Sharp & Dohme LLC
Non-randomizedSingle-groupOpen-labelTreatment

Summary

To evaluate if preservative free cosopt is well tolerated in patients with Open angle glaucoma (OAG) or Ocular hypertension (OH) with dry eyes.

Timeline

Start
2007-05-23
Primary completion
2008-09-15
Completion
2008-09-15

Publications

Drugs

EvaluationDrugModalityDoseRoute
Subject Dorzolamide Small molecule 2 % —
Subject Timolol Other / unclassified 0.5 % —

Indications

ocular hypertension open-angle glaucoma